Genetic testing for hereditary early-onset coronary heart disease and individualized medication evaluation is a genetic testing product based on Cygnus sequencer's S100 gene sequencer. It mainly detects genes associated with the risk of early-onset coronary heart disease, including LDLR, LDLRAP1, PCSK9, ABCG5, ABCG8, and APOB. This product is helpful for the early detection and prevention of the disease. Additionally, it also analyzes statin-related genes to evaluate the risk of adverse reactions and the effectiveness of statin drugs
Convenient and flexible
Authoritative and efficient
Sensitive and accurate
People with early-onset coronary heart disease and other cardiovascular diseases
People with a family history of early-onset coronary heart disease or imaging evidence of atherosclerosis
People with hypertension, hyperglycemia and hyperlipidemia (adult serum LDL-C ≥ 4.1 mmol/L)
People whose first-degree relatives have any one or all of the above three conditions
People with hypercholesterolemia and sitosterolemia
People concerned about cardiovascular health
clinical significance
indicates genetic risk
statin medication guidance
health screening
risk assessment
DNA extraction
quality control
library preparation
library quality control
sequencing
data analysis
report review
report release
7 working days after receiving qualified samples.